Robert F. Kennedy Jr. stated that there is insufficient evidence linking Tylenol (brand) use during pregnancy to risks of autism spectrum, despite recent government warnings.
- Robert F. Kennedy Jr. emphasized the lack of evidence connecting Tylenol (brand) to autism spectrum disorders, suggesting cautious use instead.
- The White House had previously advised pregnancy women and young children to limit paracetamol intake, stirring debate on its safety.
- Donald Trump has voiced support for investigating such health claims, reflecting broader concerns about medication safety during pregnancy.
Why It Matters
This discussion is crucial as it highlights the ongoing debate over medication safety during pregnancy, impacting public health policies and parental choices regarding Tylenol (brand) and potential autism spectrum risks.